Article Details

Cellular Therapy Co. Earns Rare Pediatric Disease Designation for Infant Congenital Heart ...

Retrieved on: 2021-11-20 16:53:21

Tags for this article:

Click the tags to see associated articles and topics

Cellular Therapy Co. Earns Rare Pediatric Disease Designation for Infant Congenital Heart .... View article details on hiswai:

Excerpt

Longeveron is a clinical-stage biotechnology company based in Miami, Fla. that is engaged in the development of cellular therapies for treating ...

Article found on: www.streetwisereports.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up